N@N

OMAHA, Neb.--([ BUSINESS WIRE ])--ConAgra Foods, Inc., (NYSE: CAG) announced today that it has completed its acquisition of the Bertolli and P.F. Changas Home Menu frozen meals businesses from Unilever PLC, for total cash consideration of $267 million, subject to adjustment. The company announced the acquisition agreement on July 30, 2012.

The acquisition includes the frozen meals businesses, a license for use of the Bertolli brand name and the transfer of Unileveras existing license with P.F. Changas for use of the P.F. Changas Home Menu brand name.

The addition of Bertolli and P.F. Changas Home Menu frozen meals expands ConAgra Foodsa presence in the freezer case, which includes brands such as Marie Callenderas, Banquet, Healthy Choice and Kid Cuisine.

About ConAgra Foods

ConAgra Foods, Inc., (NYSE: CAG), is one of North America's leading food companies, with brands in 97 percent of Americaas households. Consumers find Banquet, Chef Boyardee, Egg Beaters, Hebrew National, Huntas, Marie Callenderas, Orville Redenbacheras, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack and many other ConAgra Foods brands in grocery, convenience, mass merchandise and club stores. ConAgra Foods also has a strong business-to-business presence, supplying frozen potato and sweet potato products as well as other vegetable, spice and grain products to a variety of well-known restaurants, foodservice operators and commercial customers. For more information, please visit us at [ http://www.conagrafoods.com ].

Note on Forward-looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on managementas current views and assumptions of future events and financial performance and are subject to uncertainty and changes in circumstances. We undertake no responsibility for updating these statements. Readers of this release should understand that these statements are not guarantees of performance or results. Many factors could affect our actual financial results and cause them to vary materially from the expectations contained in the forward-looking statements, including those set forth in this release. These factors include, among other things: availability and prices of raw materials, including any negative effects caused by inflation; the effectiveness of our product pricing, including any pricing actions and promotional changes; future economic circumstances; industry conditions; our ability to execute our operating and restructuring plans; the success of our innovation, marketing, and cost- saving initiatives; the competitive environment and related market conditions; operating efficiencies; the ultimate impact of any product recalls; our success in efficiently and effectively integrating acquisitions; access to capital; actions of governments and regulatory factors affecting our businesses, including the Patient Protection and Affordable Care Act; the amount and timing of repurchases of our common stock, if any; and other risks described in our reports filed with the Securities and Exchange Commission. We caution readers not to place undue reliance on any forward-looking statements included in this release, which speak only as of the date of this release.